πŸ‡ΊπŸ‡Έ FDA
Patent

US 8012999

Modulators of CFTR

granted A61PA61P25/00A61P27/02

Quick answer

US patent 8012999 (Modulators of CFTR) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P25/00, A61P27/02, A61P3/00, A61P37/00